NCT04802473

Brief Summary

OrACell has been tested as a barrier in bone regenerative procedures showing promising results in new bone formation after socket preservation, but no data is available on root coverage procedures. Moreover, it has been suggested that keratinized tissue width (KTW) ≥2mm and gingival thickness (GT) ≥1.2 mm at 6 months of the surgical procedures are two important predictors for long term stability of gingival margin Therefore, it was hypothesized that soft tissue thickness and keratinized tissue width may influence the percentage of root coverage. By means of a prospective case series (12 patients in total), the aim is to study the performance of the OrACell dermal matrix in the treatment of multiple and adjacent gingival recessions, determining the amount of complete root coverage obtained at 6 months of follow-up. At the same time, it is intended to evaluate the effect of initial gingival thickness, by means of digital scanning, upon the success of root coverage procedure with OrACell.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 9, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 17, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2022

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2022

Completed
Last Updated

October 4, 2022

Status Verified

October 1, 2022

Enrollment Period

1.8 years

First QC Date

March 12, 2021

Last Update Submit

October 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complete root coverage (CRC)

    By using the buccal surfaces of the concerned teeth as reference points for the superpositioning of the different time points (pre-operative and post-operative), this approach will allow for precise evaluation of dimensional soft tissue alterations over time by a blinded examiner

    CRC 6 months after surgery

Secondary Outcomes (1)

  • : Mean Root Coverage (MRC), change in Keratinized tissue width and change in Keratinizedd tissue thickness

    6 months after surgery

Study Arms (1)

Gingival recession treatment

EXPERIMENTAL

Gingival recession treatment by means of tunnel technique and OrACell dermal matrix.

Procedure: Mucogingival surgery

Interventions

In brief description, Tunnel+acellular dermal matrix treatment will be performed by starting initial sulcular incisions, tunneling knives will be used to elevate the buccal gingiva by means of a full-thickness flap elevation. Flap preparation will be extended beyond the MGJ. The exposed root surfaces will be treated with pre-conditioning EDTA (Straumann PrefGel®) for 2 minutes. ADM (OrACELL, LifeNet Helth, Virginia Beach, VA, USA) of 1.25-1.75mm in thickness will be cut to the exact size of the defect, and will be inserted into the tunnel, and subsequently covered advancing the flap by means of sling sutures to stabilize the flap in a coronal position (6-0 Polypropylene, Prolene, Ethicon, Johnson and Johnson, New Brunswick, NJ, USA). Sutures will be removed after 14 days. Two weeks after surgery, patients will resume mechanical tooth cleaning with a soft toothbrush. Patients will be recalled at 1, 3 and 6 months for professional oral hygiene procedures.

Also known as: Treatment of adjacent multiple gingival recessions using the OrACell® dermal matrix
Gingival recession treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Periodontally and systemically healthy.
  • Presence of Cairo RT 1 and RT2 GR defects
  • Recession ≥2mm in depth at the buccal aspect.
  • Full-mouth plaque and bleeding score ≤20%.
  • No previous periodontal surgery.
  • Presence of identifiable CEJ (a step ≤1mm at the CEJ and/or presence of root abrasion, but with identifiable CEJ, will be accepted).

You may not qualify if:

  • Tobacco smoking of ≥10 cigarettes a day.
  • Contraindications for periodontal surgery.
  • Medications known to affect the gingiva or interfere with wound healing.
  • Pregnancy.
  • Active orthodontic therapy.
  • Caries or restorations in the area to be treated.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gonzalo Blasi

Barcelona, 08034, Spain

Location

MeSH Terms

Conditions

Gingival RecessionPeriodontal Attachment LossPeriodontal DiseasesSoft Tissue Injuries

Condition Hierarchy (Ancestors)

Gingival DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal AtrophyWounds and Injuries

Study Officials

  • Jose Nart, PhD

    UIC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A prospective case series with a 6-month follow-up.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chairman and Program Director, Department of Periodontology UIC-Barcelona

Study Record Dates

First Submitted

March 12, 2021

First Posted

March 17, 2021

Study Start

July 9, 2020

Primary Completion

April 15, 2022

Study Completion

April 22, 2022

Last Updated

October 4, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations